Only a handful of places left for our September 2026 cohort. Applications close soonApply now →

MSTA
Your future
starts here.

Squalane

Also known as: hydrogenated squalene, perhydrosqualene

Squalane is a saturated hydrocarbon oil used as an emollient and formulation vehicle in skincare. It helps lubricate and soften the skin surface. Its chemical stability and skin feel make it useful in moisturisers and other cosmetic preparations.

In plain English — Squalane is an oily ingredient used to soften and smooth skin. It can be part of a moisturiser or help carry other ingredients in a formula. The complete product and the person's skin response matter when deciding whether it suits them.

Evidence status

Limited

Squalane has a long-established cosmetic emollient role and an expert-panel safety assessment. Direct human hydration and clinical-use research is smaller and less controlled than its extensive formulation use might imply; outcomes from combination products remain formulation-specific.

What squalane is, and the types available#

Squalane is a saturated, branched-chain hydrocarbon. It is a clear oil, insoluble in water, with established uses as a skin lubricant, emollient and carrier in creams, lotions and other cosmetics. “Emollient” describes the softening and smoothing role that is most relevant to routine skin care.[1]

Products may deliver it within an oily preparation or as part of an emulsion containing both oil and water phases. The complete formula determines the texture and intended use. Its saturated structure gives useful oxidative stability compared with squalene.[1]

The subject here is the ingredient, formulation role and clinical evidence. The wider organisation of skin lipids and protective function belongs in stratum corneum and skin barrier.

Use of squalane in aesthetic practice#

Squalane is principally relevant when selecting moisturising care for dry or uncomfortable skin and when considering the vehicle carrying another ingredient. A product’s spreadability, greasiness and comfort can be important to its acceptability. General emollient selection is individual, including choice between lighter and more occlusive vehicles.[1][6]

The ingredient can also carry lipid-compatible materials: a clinical cosmetic study, for example, dissolved fullerene-C60 in squalane.[4]This is a useful formulation role in its own right. Discussion of the product should identify whether the intended benefit concerns moisturisation, tolerability or another active’s stated purpose.

Contraindications and cautions#

Previous reaction to the preparation or one of its constituents should guide avoidance and assessment. Inflamed skin, a new rash or persistent stinging calls for review of the skin condition and exposure history. NHS guidance distinguishes irritation from allergy and recommends identifying the responsible substance where possible.[7]

For a finished formula, check the other ingredients and intended body site as well as squalane. A preparation containing a retinoid, fragrance or another active needs assessment as that complete preparation. The cosmetic safety assessment concerns evaluated uses; special populations, procedural wounds and mucosal sites should follow the actual product’s instructions.[2]

Clinical uses and the evidence behind them#

Dryness and skin feel

Tanii and colleagues’ 1991 Japanese report included an uncontrolled use study in 50 people aged 4–76 with dry-skin disorders. A commercially supplied 99.9% squalane material was applied to affected areas including the face, hands, limbs and trunk. Recorded use varied from two days to ten months. Dryness generally improved; the design supports a clinical observation rather than a comparative treatment estimate.[3]

The same paper separately tested water retention in 16 healthy volunteers’ inner forearms. Measurements after a water-loading test, 30 and 60 minutes after squalane application, supported short-term retention. That experiment provides a physiological observation alongside the clinical-use findings.[3]

Cosmetic safety assessment

In its 2019 re-review, the Cosmetic Ingredient Review panel reaffirmed its safety conclusion for squalane and squalene under the cosmetic uses and concentrations assessed. This supports ordinary cosmetic use within that assessment’s scope.[2] CIR is funded by the Personal Care Products Council and states that its expert review process operates independently of the Council and industry.[8]

Use within an active-containing vehicle

A randomised, blinded, eight-week split-face study involved 23 Japanese women and a fullerene-C60/squalane cream. The comparator also contained squalane, without fullerene. The authors reported favourable wrinkle findings for the fullerene-containing preparation at eight weeks, while one roughness outcome did not differ significantly between preparations. The retrieved primary abstract did not disclose the full funding or author-employment record.[4]

Selecting a squalane-containing preparation#

Choose according to the intended role: an emollient component for surface comfort, or the vehicle within a more complex product. A client’s response to the texture and complete formulation matters alongside the ingredient list. For persistently dry or inflammatory skin, pharmacist or clinical input can help select a suitable emollient.[6]

When animal-origin, plant-origin or manufacturing provenance matters to a client, obtain a product-specific supplier statement. Historical animal-derived routes, olive-derived material and synthetic production are all documented.[1, 4, 5]iKuraray’s product page verifies its synthetic route; its promotional efficacy language is not required to establish that fact.[1, 4, 5]i

Adverse effects and their management#

The clinical-use report recorded four adverse responses among its 50 participants, resolving after the material was stopped. The report advises care in inflamed skin; it does not establish a universal diagnosis for the reactions.[3]

With any emollient preparation, persistent burning, new follicular inflammation or worsening facial eruptions warrants advice about whether to change the product. Symptoms after a multi-ingredient formula do not identify which constituent is responsible.[6] Record the product and timing, avoid the suspected cause and arrange assessment where symptoms continue.[7]

Emollient residue in fabrics creates a fire hazard. The NHS precaution includes paraffin-free preparations: clothing and bedding exposed to the product should be kept away from smoking and flames.[6]

Referral and scope boundaries#

Persistent, recurrent or severe dermatitis warrants medical assessment, with specialist investigation when the cause is unclear or treatment is unsuccessful.[7] Squalane-containing supportive care can be considered within that assessment; an ingredient preference should not delay it.

This is an entry on topical cosmetic use. It does not provide a disease-treatment protocol or authorise a product for injection, procedural wounds or other routes. Care after an aesthetic procedure follows the treating clinician’s and relevant manufacturer’s instructions.

Mechanism of action#

Squalane’s primary formulation role is physical: it provides an oily, lubricating component at the skin surface. Its water-insoluble character distinguishes that role from water-binding ingredients in the same moisturiser.[1] In the small forearm experiment, the relevant observation was retention after water loading rather than added water supplied by the oil itself.[3]

For broader interpretation, TEWL explains measurements of water-vapour loss. Surface softness, water-retention measurements and treatment of an inflammatory disorder are different outcomes that should be named when discussing a product.

Commonly misstated claims#

Squalane and squalene

Claim heard:“Squalane is simply another spelling of squalene”

Literature finding: Squalane is saturated, with formula C30H62; squalene is unsaturated, with formula C30H50. This difference affects chemical behaviour, including susceptibility to oxidation.[1]

Supported statement: Specify squalane or squalene accurately when describing an ingredient or applying a study.

Carrier ingredients in combination studies

Claim heard:“The fullerene trial proves squalane reduces wrinkles”

Literature finding: Both study creams contained squalane. The comparison tested adding fullerene to that formulation, so the between-group result cannot establish an independent effect of the shared carrier.[4]i

Supported statement: The reported wrinkle benefit belongs to the tested fullerene-containing preparation and comparison.

Raw-material origins

Claim heard:“The word squalane guarantees a plant-derived ingredient”

Literature finding: Sources document different production routes: the older safety assessment describes animal-derived manufacture, the fullerene paper used olive-derived squalane, and Kuraray describes synthetic manufacture.[1, 4, 5]i

Supported statement:Verify the actual material’s origin from its supplier rather than inferring it from the ingredient name.

Areas of remaining uncertainty#

  • Comparative product choice:the direct clinical-use report was uncontrolled. A product’s suitability relative to other emollients therefore also depends on intended use, comfort and observed skin response.[3][6]
  • Defined populations and duration: the older report covered mixed disorders, body sites and variable use periods. Consistent studies would make benefit estimates more useful for a particular facial or body presentation.[3]
  • Patient-valued outcomes: future comparisons could assess sustained comfort and acceptability alongside measurements. These are relevant selection considerations when the practical aim is comfortable daily skin care.[3][6]

Frequently asked questions#

Why is squalane useful in a moisturiser?

It supplies an emollient, lubricating oil component and can serve as a carrier within the formulation.[1]

Does an oily texture determine whether a product will suit someone?

Vehicle preference and skin response both matter. NHS guidance recognises that an individual may need to try different emollient preparations to find a suitable one.[6]

Which entries explain the other components of barrier care?

See panthenol for a humectant ingredient and ceramides for that lipid family. Impaired skin barrier addresses the clinical presentation and differential when the concern is symptoms rather than an ingredient.

References#

Each source is graded by evidence tier. Tier 4 material (manufacturer documents, expert consensus, practitioner experience) is useful for protocol and context, and is never presented as equivalent to independent clinical evidence.

  1. Cosmetic Ingredient Review; Elder RL, editor. Final Report on the Safety Assessment of Squalane and Squalene. J Am Coll Toxicol. 1982;1(2):37–56. doi:10.3109/10915818209013146.Tier 4Supports: Chemical identity, stability, emollient/vehicle function and historical manufacturing routes.Funding / interest: CIR expert-panel assessment drawing partly on industry-submitted data. CIR's trade-association funding is documented by source 8; a separate article-specific funding statement was not identified in this older report.
  2. Cosmetic Ingredient Review Expert Panel. Squalane and Squalene: re-review summary. June 2019.Tier 4Supports: Reaffirmation of cosmetic safety under the uses and concentrations assessed.Funding / interest: Industry-funded CIR programme; updated use data included Personal Care Products Council submissions. Programme funding and stated independence of its review process are documented in source 8.
  3. Tanii T, Katoh J, Yashiro N, Shindo K, Kono T, Hamada T, Yamaguchi M. Clinical Evaluations of Squalane in Patients with Xerotic Dermatoses and the Results of Patch Test of Squalane and its Moisturizing Effects. Skin Research. 1991;33(2):155–163. doi:10.11340/skinresearch1959.33.155.Tier 3Supports: Distinct uncontrolled clinical-use, diagnostic patch-test and forearm water-retention investigations.Funding / interest: Methods disclose commercially supplied 99.9% squalane from the company named ローザ社. No separate funding/conflict declaration was identified. Original Japanese full text and English abstract retrieved; study tables visually checked. Not a randomised efficacy trial.
  4. Kato S, Taira H, Aoshima H, Saitoh Y, Miwa N. Clinical evaluation of fullerene-C60 dissolved in squalane for anti-wrinkle cosmetics. J Nanosci Nanotechnol. 2010;10(10):6769–6774. doi:10.1166/jnn.2010.3053. PMID:21137794.Tier 2Supports: Squalane's carrier role and correct attribution of a fullerene-versus-vehicle comparison.Funding / interest: Named commercial ingredient LipoFullerene; original sponsor and full author-employment/conflict statements unavailable in the retrieved abstract. Independence is not established from the university affiliation.
  5. Kuraray. Squalane. Official product information. Accessed 16 September 2026.Tier 4Supports: Existence of a synthetic manufacturing route for the supplier's ingredient.Funding / interest: Commercial supplier's own product page. Used for manufacturing identity, not independent proof of efficacy, superiority or market exclusivity.
  6. NHS. Emollients. Public patient guidance. Accessed 16 September 2026.Tier 4Supports: Emollient selection, skin reactions and fire precautions.Funding / interest: NHS public guidance; not ingredient-sponsored research.
  7. NHS. Contact dermatitis. Reviewed 3 May 2023. Accessed 16 September 2026.Tier 4Supports: Exposure avoidance and medical assessment of persistent, recurrent or severe dermatitis.Funding / interest: NHS public guidance; not ingredient-sponsored research.
  8. Cosmetic Ingredient Review. About the Cosmetic Ingredient Review. Accessed 16 September 2026.Tier 4Supports: Programme funding and the organisation's stated independence of its review process.Funding / interest: CIR's own institutional disclosure states funding by the Personal Care Products Council. Institutional provenance only, not clinical evidence.